Page last updated: 2024-10-17

dihydrolipoic acid and Cystic Fibrosis

dihydrolipoic acid has been researched along with Cystic Fibrosis in 1 studies

dihydrolipoic acid: RN given refers to parent cpd without isomeric designation
dihydrolipoic acid : A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects.
dihydrolipoate : The conjugate base of dihydrolipoic acid.

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, RL1
Rancourt, RC1
del Val, G1
Pack, K1
Pardee, C1
Accurso, FJ1
White, CW1

Other Studies

1 other study available for dihydrolipoic acid and Cystic Fibrosis

ArticleYear
Thioredoxin and dihydrolipoic acid inhibit elastase activity in cystic fibrosis sputum.
    American journal of physiology. Lung cellular and molecular physiology, 2005, Volume: 289, Issue:5

    Topics: Adult; Animals; Child; Cystic Fibrosis; Enzyme Inhibitors; Escherichia coli Proteins; Humans; In Vit

2005